FDA Approved: TOUJEO — Original Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

FDA approved Toujeo (insulin glargine) through its original application, establishing a concentrated long-acting insulin product for glycemic control in people …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• TOUJEO (insulin glargine)

Snippet

ORIG AP for TOUJEO (INSULIN GLARGINE)